echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Roche's new anti-influenza drug Xofluza will soon be approved in China

    Roche's new anti-influenza drug Xofluza will soon be approved in China

    • Last Update: 2021-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 25, the official website of NMPA showed that the review status of Roche’s new anti-influenza drug Mabaloxavir Tablets (Xofluza) (acceptance number JXHS2000074/75) was changed to "under approval", which means that this new mechanism of action Innovative anti-influenza drugs are not far from being launched in China.


    Xofluza was developed by Shiono Yoshihide, a Japanese pharmaceutical company.


    In February 2018, Xofluza was the first to be approved in Japan for the treatment of influenza caused by influenza A and B strains; in October 2018, it was approved by the FDA for the treatment of acute and Simple flu.


    Xofluza is a single-dose oral drug with a brand-new anti-influenza mechanism of action.


    The currently widely used anti-influenza oral medications are neuraminidase inhibitor antiviral drugs (oseltamivir), which need to be taken twice a day for 5 consecutive days.


    In a multi-center, randomized, double-blind phase 3 clinical study, the enrolled volunteers were administered Xofluza, oseltamivir, and placebo.


    In addition, Xofluza can also target the Tamiflu resistant strains of the avian influenza viruses H5N1 and H7N9.


    At present, Xofluza has been approved in many countries and regions around the world, and it is approved in Japan for the treatment of influenza A or B virus infection; in the United States, Singapore, Thailand, Hong Kong and Taiwan, etc.


    On March 26, 2020, Roche’s Genentech announced that the U.


    According to the Insight database (https://db.


    I wonder how the new drug will be priced after it is launched in China? Can you give a more affordable price?

    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.